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Abstract
Background: The perioperative use of high inspired oxygen fraction (FIO2) for preventing surgical site infections
(SSIs) has demonstrated a reduction in their incidence in some types of surgery however there exist some
discrepancies in this respect. The aim of this study was to analyze the relationship between PaO2 values and SSIs in
cardiac patients.
Methods: We designed a prospective study in which 1,024 patients undergoing cardiac surgery were analyzed.
Results: SSIs were observed in 5.3% of patients. There was not significant difference in mortality at 30 days
between patients with and without SSIs. In the uni and multivariate analysis no differences in function of the
inspired oxygen fraction administrated were observed.
Conclusions: We observed that the PaO2 in adult cardiac surgery patients was not related to SSI rate.
Dear Editor,
The potential clinical benefits of the perioperative use
of high inspired oxygen fraction (FIO2) for preventing
surgical site infections (SSIs) have attracted great inter-
est in recent years. Trials by Greif et al. [1] and Belda
et al. [2] demonstrated that SSIs decreased significantly
following colon surgery in patients who received 80%
oxygen intraoperatively and for the first hours following
surgery.
In the sphere of cardiac surgery, SSIs are serious
complications associated with extended hospital stay,
increased hospital costs, and higher mortality and mor-
bidity rates [3]. Thus, in 2005 our Department of
Anesthesiology and Reanimation adopted a clinical
strategy of administering 50% oxygen without nitrous
oxide during anesthesia and for the first 6 postopera-
tive hours in an effort to decrease SSIs.
In contrast to the findings of Belda et al. [2], clinical
trials by Pryor et al. [4] and, more recently, by Meyhoff
et al. [5], found no difference in SSI risk when 80% oxy-
gen rather than 30% oxygen was administered during
abdominal surgery and for 2 hours postoperatively.
Their findings suggested that perioperative hyperoxia
was not effective in reducing SSIs. These reports add to
the evidence base surrounding the potential role of high
FIO2 in SSI prevention.
The rationale for administering high FIO2 to prevent
SSIs is to produce a high PaO2 and thereby increase the
PsqO2 (tissue oxygen partial pressure), since oxidative
killing by neutrophils is the primary defense against sur-
gical pathogens. The risk of infection is thus inversely
related to PsqO2 [3]. Our aim in this study was to ana-
lyze the relationship between PaO2 values and SSIs.
We designed a prospective study that analyzed the data
from 1,024 consecutive patients who underwent cardiac
surgery with extracorporeal circulation at our institution
from January 30, 2007 to June 30, 2009. Transplant
patients were excluded. The patients were categorized
according to the presence or absence of SSIs. The study
was approved by the hospital’s Research Commission,
and all participants provided informed written consent.
The Center for Disease Control and Prevention (CDC)
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reproduction in any medium, provided the original work is properly cited.Table 1 Characteristics and preoperative, intraoperative, and postoperative data for patients with and without
surgical site infections (SSIs)
Characteristics Patients
Without SSI
(n = 970)
Patients
With SSI
(n = 54)
Univariate OR
(95% CI)
P
value
Adjusted OR
(95% CI)
b
P
value
Preoperative value
Age, mean (SD), years 68.2 ± 10,1 69.07 ± 10,9 1.009 (0.981 to 1.03) 0.54
Sex, male/female 591 (60.9)/379 (39.1) 37 (68.5)/17 (31.5) 1.396 (0.77 to 2.51) 0.26
Underlying conditions, No. (%)
Diabetes mellitus 285 (29.4) 16 (29.6) 1.01 (0.55 to 1.84) 0.97
Hypertension 427 (44) 27 (50) 1.27 (0.73 to 2.28) 0.39
Chronic renal failure 50 (5.2) 2 (3.7) 0.70 (0.16 to 2.98) 0.64
Chronic obstructive pulmonary
disease
202 (20.8) 18 (33.3) 1.90 (1.05 to 3.41) 0.03
Peripheral vascular disease
a 74 (7.6) 2 (3.7) 0.28
Additional drugs, No (%)
b-blockers
a 435 (44.9) 21 (38.9) 1.28 (0.72 to2.27) 0.39
Statin 373 (38.5) 23 (42.6) 0.84 (0.48 to 1.47) 0.55 1.29(0.71 to2.33) 0.39
Corticosteroids 19 (2.0) 1 (1.9) 0.94 (0.12 to 7.19) 0.95
Intraoperative values
Antibiotic prophylaxis, No. (%)
Cefazolin 938 (96.7) 46 (85.2) 0.19 (0.008 to 0.44) 0.001 4.90(2.07 to11.61) 0.0001
Teicoplanin 32 (3.3) 8 (14.8) 0.001
Surgical procedure, No. (%)
Valve 490 (50.5) 31 (57.4) 1.33 (0.76 to2.32) 0.32
CABG 296 (30.5) 14 (25.9) 0.8 (0.42 to 1.49) 0.47
Valvular + CABG 184 (19.0) 9 (16.7) 0.85 (0.41 to 1.78) 0.67
Total CPB time, mean (SD), min 92.8 ± 38.2 96.3 ± 35.7 1.002 (0.99 to 1.009) 0.502 1.001(0.99
to1.009)
0.77
Aortic cross-clamp time, mean (SD), min
a 66.7 ± 29.04 69.5 ± 26.6 1.003 (0.99 to 1.01) 0.48
Glucose, mean (SD), mg/dL
a 180.2 ± 51.4 178.5 ± 48.5 0.99 (0.98 to 1.001) 0.07 1.00(0.99 to1.01) 0.95
PaO2, mean (SD), mm Hg
a 148.4 ± 38.4 150.1 ± 34.2 1.001 (0.99 to 1.008) 0.74
Hematocric during CPB, mean (SD), (%) 26.5 ± 4.4 25.8 ± 3.7 0.25
Postoperative
Duration of mechanical ventilation, mean
(SD), days
51.4 ± 200.7 44.5 ± 146.3 0.805
Glucose, mean, mg/dL 1-h ICU admission 166.2 ± 47.5 159.6 ± 52.4 1.001 (0.99 to 1.008) 0.32 0.99(0.98 to1.01) 0.19
8-h ICU post-admission
a 169.1 ± 63.02 156.30 ± 40.8 0.996 (0.98 to 1.003) 0.14
Core temperature, ICU admission, mean,°C 36.1 ± 0.7 36.1 ± 0.6 1.152 (0.78 to 1.696) 0.47 1,13(0.74 to1.71) 0.56
PaO2, mean (SD), mm Hg 1-h ICU post-
admission
134.8 ± 41.3 136.5 ± 39.5 0.77 1.00(0.99 to1.01) 0.29
8-h ICU post-admission 130.1 ± 37.5 124.4 ± 34.02 0.27 0.99(0.98 to1.00) 0.22
Leukocyte, ICU admission, mean (SD),mm
3 10934.5 ± 3826.5 11316.4 ± 3611.01 1.000 (1.000 to1.000) 0.47
Hematocric, ICU admission, mean (SD), (%) 30.3 ± 4.7 31.5 ± 4.0 1.06 (0.99 to 1.12) 0.06
Units red-cell transfusion, mean (SD) 2.02 ± 2.8 2.2 ± 2.5 1,027 (0.94 to 1.121) 0.54
Mediastinal bleeding, mean (SD), mm
3 828.9 ± 554.3 709.9 ± 92.5 1.000 (0.99 to 1.000) 0.03
Complications, No. (%)
Cardiac 72 (7.4) 6 (11.1) 1.5 (0.64 to 3.75) 0.32
Respiratory failure 89 (9.2) 3 (5.7) 0.59 (0.18 to 1.93) 0.38
Stroke 20 (2.1) 2 (3.7) 1.82 (0.41 to 8.0) 0.42
Acute renal failure 61 (6.3) 8 (14.8) 2.63 (1.17 to 5.88) 0.01
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package (version 15) was used for statistical analysis.
A p ≤ 0.05 was considered significant.
To assess risk factors for SSI, we used one-way analysis
of variance for univariate continuous variables and the
chi-square test for categorical variables. In addition, we
conducted Fisher’s exact test whenever the chi-square
expected value of at least one cell was less than 5.
We avoided multicollinearity among the explanatory
variables by performing collinearity diagnostic analyses.
We performed the stepwise selection of variables from
the models with the following criteria: Tolerance greater
than 0.4 or variance inflation less than 2.5, condition
number less than 10, and a variance of two or more
variables no greater than 0.5.
SSIs developed after cardiac surgery in 54 (5.3%)
patients, 28 (2.8%) superficial or deep incision SSIs and
26 (2.5%) organ/space SSIs. The intraoperative and post-
operative PaO2 values were not associated with an
increased risk of SSI either by univariate or multivariate
analysis (Table 1). The 30-day mortality rate was similar
in both groups: patients without SSIs, n = 72 (7.4%) vs.
patients with SSIs, n = 4 (7.4%); (P = .11).
Our results agree with the results of the trials conducted
by Pryor et al. [4] and Meyhoff et al. [5] in that periopera-
tive hyperoxia was not effective in reducing SSIs. PsqO2 is
typically lower than the PaO2 level by a factor of two to
four. As might be expected, tissue oxygenation improves
much less than arterial oxygen in response to supplemen-
tal oxygen administration. Sternal wound oxygenation
increased by an average of 4 mm Hg (from 23 to 27 mm
Hg) with supplemental oxygen at 50% [3].
The data from prior studies [4,5], as well as the pre-
sent results, leads us to question our policy to routinely
administer a high inspired oxygen fraction to cardiac
surgery patients in order to prevent SSIs. In summary,
the PaO2 in adult cardiac surgery patients is not related
to SSI rate. The strategy of administering supplemental
inspired oxygen to reduce the incidence of SSIs does
not appear to be clinically useful.
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